Kala Pharmaceuticals Reports EYSUVIS Coverage on UnitedHealthcare Commercial and Cigna Medicare
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) has reported that UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies effective March 2022. EYSUVIS has covered 118 million lives or 70% of all commercial lives. “Today’s announcement marks significant progress...